RedCo II Master Fund, L.P.
Insider CIK 1921783 · MDVL Director, 10% owner · FATE Director, 10% owner · AUGX Director, 10% owner · ADCT 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FATE FATE THERAPEUTICS INC | J Other deriv | 2026-04-20 | 2026-04-22 | 266,280 | — | $0 | 0 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other deriv | 2026-04-20 | 2026-04-22 | 162,013 | — | $0 | 0 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other deriv | 2026-04-20 | 2026-04-22 | 266,280 | — | $0 | 502,769 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other deriv | 2026-04-20 | 2026-04-22 | 162,013 | — | $0 | 2,755,086 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other deriv | 2026-04-20 | 2026-04-22 | 3,691,324 | — | $0 | 3,893,674 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other deriv | 2026-04-20 | 2026-04-22 | 3,691,324 | — | $0 | 0 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other deriv | 2026-04-20 | 2026-04-23 | 266,280 | — | $0 | 502,769 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other deriv | 2026-04-20 | 2026-04-23 | 266,280 | — | $0 | 0 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other | 2026-04-20 | 2026-04-22 | 8,977,624 | — | $0 | 0 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other | 2026-04-20 | 2026-04-22 | 8,977,624 | — | $0 | 12,884,277 | SEC↗ |
| ADCT ADC Therapeutics SA | S Sale | 2026-04-02 | 2026-04-02 | 2,529,491 | $3.28 | $8.30M | 10,265,297 | SEC↗ |
| ADCT ADC Therapeutics SA | S Sale | 2026-04-02 | 2026-04-02 | 2,634,506 | $3.28 | $8.64M | 12,666,731 | SEC↗ |
| ADCT ADC Therapeutics SA | S Sale | 2026-04-01 | 2026-04-02 | 169,265 | $3.80 | $643.2K | 15,301,237 | SEC↗ |
| ADCT ADC Therapeutics SA | S Sale | 2026-04-01 | 2026-04-02 | 162,517 | $3.80 | $617.6K | 12,794,788 | SEC↗ |
| ADCT ADC Therapeutics SA | S Sale | 2026-03-31 | 2026-04-02 | 188,407 | $3.75 | $706.5K | 12,957,305 | SEC↗ |
| ADCT ADC Therapeutics SA | S Sale | 2026-03-31 | 2026-04-02 | 196,229 | $3.75 | $735.9K | 15,470,502 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2025-10-27 | 2025-10-28 | 3,846,153 | $3.90 | $15.00M | 3,846,153 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2025-10-27 | 2025-10-28 | 3,846,153 | $3.90 | $15.00M | 3,846,153 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2025-06-11 | 2025-06-13 | 15,734,267 | $3.43 | $53.97M | 15,734,267 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2025-06-11 | 2025-06-13 | 12,465,234 | $3.43 | $42.76M | 12,465,234 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy | 2024-12-11 | 2024-12-13 | 50,000 | $3.81 | $190.5K | 15,666,731 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy | 2024-12-11 | 2024-12-13 | 50,000 | $3.81 | $190.5K | 13,145,712 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy | 2024-12-11 | 2024-12-13 | 50,000 | $2.28 | $114.0K | 15,616,731 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy | 2024-12-11 | 2024-12-13 | 50,000 | $2.28 | $114.0K | 13,095,712 | SEC↗ |
| ADCT ADC Therapeutics SA | J Other deriv | 2024-12-04 | 2024-12-06 | 26,656 | $2.07 | $55.2K | 8,136,609 | SEC↗ |
| ADCT ADC Therapeutics SA | J Other deriv | 2024-12-04 | 2024-12-06 | 26,656 | $2.07 | $55.2K | 8,163,265 | SEC↗ |
| ADCT ADC Therapeutics SA | J Other deriv | 2024-12-04 | 2024-12-06 | 26,656 | $2.07 | $55.2K | 6,133,837 | SEC↗ |
| ADCT ADC Therapeutics SA | J Other | 2024-12-04 | 2024-12-06 | 50,672 | $2.07 | $104.9K | 13,045,712 | SEC↗ |
| ADCT ADC Therapeutics SA | J Other | 2024-12-04 | 2024-12-06 | 50,672 | $2.07 | $104.9K | 15,516,059 | SEC↗ |
| ADCT ADC Therapeutics SA | J Other | 2024-12-04 | 2024-12-06 | 50,672 | $2.07 | $104.9K | 15,566,731 | SEC↗ |
| ADCT ADC Therapeutics SA | S Sale | 2024-12-04 | 2024-12-06 | 25,352 | $2.07 | $52.5K | 15,566,731 | SEC↗ |
| AUGX Augmedix, Inc. | D To issuer deriv | 2024-10-02 | 2024-10-04 | 1,093,799 | — | $0 | 0 | SEC↗ |
| AUGX Augmedix, Inc. | D To issuer deriv | 2024-10-02 | 2024-10-04 | 1,093,799 | — | $0 | 0 | SEC↗ |
| AUGX Augmedix, Inc. | D To issuer deriv | 2024-10-02 | 2024-10-04 | 3,125,195 | — | $0 | 0 | SEC↗ |
| AUGX Augmedix, Inc. | D To issuer deriv | 2024-10-02 | 2024-10-04 | 3,125,195 | — | $0 | 0 | SEC↗ |
| AUGX Augmedix, Inc. | D To issuer | 2024-10-02 | 2024-10-04 | 9,446,146 | $2.35 | $22.20M | 0 | SEC↗ |
| AUGX Augmedix, Inc. | D To issuer | 2024-10-02 | 2024-10-04 | 6,218,238 | $2.35 | $14.61M | 0 | SEC↗ |
| AUGX Augmedix, Inc. | D To issuer | 2024-10-02 | 2024-10-04 | 16,421,788 | $2.35 | $38.59M | 0 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy | 2024-07-01 | 2024-07-03 | 400,000 | $2.81 | $1.12M | 15,669,217 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy | 2024-07-01 | 2024-07-03 | 400,000 | $2.81 | $1.12M | 12,995,040 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-05-08 | 2024-05-10 | 6,107,181 | $4.81 | $29.38M | 6,107,181 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-05-08 | 2024-05-10 | 8,163,265 | $4.81 | $39.27M | 8,163,265 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-02-07 | 2024-02-09 | 107,590 | — | $0 | 107,590 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-02-02 | 2024-02-09 | 144,517 | — | $0 | 144,517 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-02-02 | 2024-02-09 | 11,159 | — | $0 | 11,159 | SEC↗ |
| ADCT ADC Therapeutics SA | J Other deriv | 2024-02-01 | 2024-02-09 | 19,700 | $3.38 | $66.6K | 1,180,136 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-02-01 | 2024-02-09 | 205,483 | — | $0 | 205,483 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-02-01 | 2024-02-09 | 15,867 | — | $0 | 15,867 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-31 | 2024-02-09 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-30 | 2024-02-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-29 | 2024-02-09 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-26 | 2024-02-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-25 | 2024-02-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-24 | 2024-02-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-16 | 2024-02-09 | 53,900 | — | $0 | 53,900 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-12 | 2024-02-09 | 93,424 | — | $0 | 93,424 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-11 | 2024-02-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-10 | 2024-02-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-09 | 2024-02-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-08 | 2024-02-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-05 | 2024-02-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-04 | 2024-02-09 | 28,652 | — | $0 | 28,652 | SEC↗ |
| ADCT ADC Therapeutics SA | J Other deriv | 2024-01-03 | 2024-02-09 | 59,986 | $1.68 | $100.8K | 1,199,836 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-03 | 2024-02-09 | 56,900 | — | $0 | 56,900 | SEC↗ |
| AUGX Augmedix, Inc. | A Award deriv | 2023-11-20 | 2023-11-22 | 1,093,799 | — | $0 | 1,093,799 | SEC↗ |
| AUGX Augmedix, Inc. | A Award deriv | 2023-11-20 | 2023-11-22 | 1,093,799 | — | $0 | 1,093,799 | SEC↗ |
| AUGX Augmedix, Inc. | P Buy | 2023-11-20 | 2023-11-22 | 750,000 | $4.00 | $3.00M | 16,404,017 | SEC↗ |
| AUGX Augmedix, Inc. | P Buy | 2023-11-20 | 2023-11-22 | 750,000 | $4.00 | $3.00M | 9,446,146 | SEC↗ |
| MDVL MedAvail Holdings, Inc. | A Award deriv | 2023-06-16 | 2023-06-21 | 38,916,562 | — | $0 | 38,916,562 | SEC↗ |
| MDVL MedAvail Holdings, Inc. | A Award deriv | 2023-06-16 | 2023-06-21 | 38,916,562 | — | $0 | 38,916,562 | SEC↗ |
| MDVL MedAvail Holdings, Inc. | A Award deriv | 2023-03-09 | 2023-03-13 | 38,916,562 | $0.32 | $12.45M | 38,916,562 | SEC↗ |
| MDVL MedAvail Holdings, Inc. | A Award deriv | 2023-03-09 | 2023-03-13 | 38,916,562 | $0.32 | $12.45M | 38,916,562 | SEC↗ |
| MDVL MedAvail Holdings, Inc. | A Award deriv | 2022-07-01 | 2022-07-06 | 3,819,558 | — | $0 | 9,548,897 | SEC↗ |
| MDVL MedAvail Holdings, Inc. | A Award deriv | 2022-07-01 | 2022-07-06 | 4,705,881 | — | $0 | 12,069,628 | SEC↗ |
| MDVL MedAvail Holdings, Inc. | A Award | 2022-07-01 | 2022-07-06 | 9,411,765 | $1.06 | $9.98M | 34,604,516 | SEC↗ |
| MDVL MedAvail Holdings, Inc. | A Award | 2022-07-01 | 2022-07-06 | 7,639,117 | $1.06 | $8.10M | 19,097,796 | SEC↗ |